WebJun 1, 2024 · Package insert / product label Generic name: Gemcitabine hydrochloride Dosage form: injection, powder, lyophilized, for solution Drug class: Antimetabolites Medically reviewed by Drugs.com. Last updated on Jun 1, 2024. On This Page Indications and Usage Dosage and Administration Dosage Forms and Strengths Contraindications … WebDec 4, 2024 · Cisplatin/ Vinblastine/ Dacarbazine ... and high-dose systemic corticosteroids should by initiated according to specific recommendations in the drug package insert. ... [package insert]. North ...
CISplatin Injection - Food and Drug Administration
WebSep 15, 2024 · For directions for the administration of cyclophosphamide, refer to the cyclophosphamide package insert. In combination therapy, cisplatin (cisplatin … WebAug 30, 2024 · Cisplatin Injection, is a clear, light-yellow, sterile aqueous solution, for intravenous use, available in sterile multiple-dose vials containing 50 mg/50 mL (1 mg/mL) 100 mg/100 mL (1 mg/mL) 4 CONTRAINDICATIONS Cisplatin Injection is contraindicated in patients with severe hypersensitivity to cisplatin [see Warnings and Precautions (5.4)]. include footer in php
Gemcitabine: Package Insert - Drugs.com
WebCisplatin is administered through a vein (intravenously or IV) as an infusion. There is no pill form of cisplatin. Cisplatin is an irritant. An irritant is a chemical that can cause inflammation of the vein through which it is given. If cisplatin escapes from the vein it can cause tissue damage. WebPatients should receive appropriate hydration prior to and/or after receiving cisplatin. See cisplatin package insert for more information. 2.2 Single-Agent Use . Non-Small Cell Lung Cancer The recommended dose of ALIMTA is 500 mg/m. 2. administered as an intravenous infusion over 10 minutes on Day 1 of each WebAug 30, 2024 · Cisplatin Injection, is a clear, light-yellow, sterile aqueous solution, for intravenous use, available in sterile multiple-dose vials containing 50 mg/50 mL (1 … include for atoi